This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Venaxis Inc
APPY : NASDAQ : Health Care
$2.30 0.02 | 0.88%
Today's Range: 2.25 - 2.32
Avg. Daily Volume: 253,700
07/11/14 - 1:00 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
APPY VENAXIS INC 2.36 73.08 n/m 0.20 162.66
CVM CEL-SCI CORP 1.19 78.51 n/m 0.31 79.19
PIP PHARMATHENE INC 1.41 76.81 n/m 15.18 -40.48
KBIO KALOBIOS PHARMACEUTICALS INC 2.31 76.19 n/m 0.03 -72.82
CYCC CYCLACEL PHARMACEUTICALS 3.23 75.89 n/m 1.27 351.24
OGXI ONCOGENEX PHARMACEUTICALS 3.62 73.53 n/m 36.54 53.16
OGEN ORAGENICS INC 2.00 72.26 n/m 1.07 -4.97
CLSN CELSION CORP 3.38 67.36 n/m 0.50 300.00
LPTN LPATH INC 3.93 61.26 n/m 8.59 70.41
ADXS ADVAXIS INC 3.13 60.33 n/m 1.00 n/a
HEB HEMISPHERX BIOPHARMA INC 0.32 58.83 n/m 0.18 0.54
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

APPY Ind Avg S&P 500
n/m 58.63 19.71
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs